Quantamental Technologies LLC Allakos Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $155,919 - $322,976	-2,345 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$31.0 - $89.73 $60,295 - $174,524	1,945 Added 486.25%	2,345 $184,000
Q2 2019 Aug 12, 2019	SELL	$36.0 - $44.73 $3,600 - $4,473	-100 Reduced 20.0%	400 $17,000
Q1 2019 Apr 29, 2019	BUY	$33.79 - $51.99 $16,895 - $25,995	500 New	500 $20,000

103

77.2M

70.7K

2.8K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $72.9M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.